Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-06-28
1992-06-09
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514252, 514269, 514274, 514333, 544310, 544316, 544319, 544333, 544405, 546256, 546257, 546258, 546266, A61K 3144, C07D40914
Patent
active
051207486
ABSTRACT:
Substituted 1,2,3,6-tetrahydropyridines are described, as well as methods for the preparation and pharmaceutical composition of same, which are useful as central nervous system agents and are particularly useful as dopaminergic, antipsychotic, and antihypertensive agents as well as for treating hyperprolactinaemia-related conditions and central nervous system disorders.
REFERENCES:
patent: 4617309 (1986-10-01), Bottcher et al.
patent: 4743692 (1988-05-01), Teller et al.
patent: 4870087 (1989-09-01), Gottschlich et al.
patent: 4942169 (1990-07-01), Sugimoto et al.
patent: 5045550 (1991-09-01), Jaen et al.
Caprathe Bradley W.
Jaen Juan C.
Wise Lawrence D.
Ivy C. Warren
Tinney Francis J.
Turnipseed James H.
Warner-Lambert & Company
LandOfFree
Substituted 1,2,3,6-tetrahydropyridines as central nervous syste does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 1,2,3,6-tetrahydropyridines as central nervous syste, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 1,2,3,6-tetrahydropyridines as central nervous syste will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1804781